Anthropic's AI-powered drug developer Mithril Medicine has advanced a potential treatment for a rare muscle-wasting disease to animal testing, showing improved muscle strength and survival in mice. The research, coordinated using AI tools across 11 labs, reached this stage in under 18 months. If further experiments succeed, human trials could begin as early as late 2028. This development highlights AI's potential to accelerate drug discovery and improve treatment timelines for serious diseases.
Anthropic's AI-powered drug developer Mithril Medicine is the subject, with Pluang market data provided for context as of Nov 12, 2026 08:41 WIB. For readers following cryptocurrency markets, here is Pluang's snapshot: of 50 major cryptocurrencies, 15 rose and 34 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, ENJ at Rp410 down 4.11%, and AAVE at Rp2.158.741 down 3.71% with a buy order activity of 64%.
Digital Turbine delayed its Q2 2027 financial results, then restated prior financials due to $3.5 million in understated revenue share expenses. This caused the stock to drop sharply, falling over 35% after the restatement. A law firm is investigatin...
AtlasClear Holdings announced the signing of its ninth correspondent broker-dealer agreement through its subsidiary AtlasClearing, contributing to an 85% revenue increase to $20.1 million in fiscal 2026. This growth occurred before significant revenu...
Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share, payable on December 15, 2026, to shareholders of record as of December 1, 2026. This dividend reflects the company's ongoing commitment to returning value to sha...
According to a Nov. 11 post by The Bitcoin Historian, Fidelity's Bitcoin exposure connected to Strategy (MSTR) increased by more than 130%, reaching a value of over $123.7 million. This significant rise highlights growing institutional interest in Bi...
The QNT cryptocurrency token fell by $12 within four hours to $164 on Binance's QNT/USDT spot market, marking a 9.5% loss over 24 hours. This decline reflects a significant short-term drop from $176 earlier the same day. Liquidations of long position...
